Encompass More Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$641K Buy
2,525
+340
+16% +$79.2K 0.09% 132
2026
Q1
$534K Buy
2,185
+81
+4% +$18.9K 0.09% 130
2025
Q4
$436K Sell
2,104
-19
-0.9% -$3.76K 0.08% 153
2025
Q3
$394K Buy
2,123
+358
+20% +$61.3K 0.08% 147
2025
Q2
$270K Sell
1,765
-358
-17% -$55K 0.06% 168
2025
Q1
$352K Sell
2,123
-33
-2% -$5.16K 0.11% 140
2024
Q4
$312K Sell
2,156
-300
-12% -$46.5K 0.1% 146
2024
Q3
$398K Buy
+2,456
New +$391K 0.15% 116

Other funds holding JNJ

Encompass More Asset Management's JNJ Position: Q2 2026 in Review

Encompass More Asset Management increased its Johnson & Johnson (JNJ) stake by 16% in Q2 2026, buying an estimated $79.2K and bringing the position to 2,525 shares worth $641K. The position accounts for 0.09% of the portfolio, ranked #132.

Encompass More Asset Management first reported a position in JNJ in Q3 2024 and has held it in 8 quarters since. 828 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Encompass More Asset Management held 2,525 shares of Johnson & Johnson worth $641K as of Q2 2026.
  • Encompass More Asset Management bought 340 Johnson & Johnson shares in Q2 2026, an estimated $79.2K.
  • Johnson & Johnson made up 0.09% of Encompass More Asset Management's portfolio in Q2 2026, its #132 holding.
  • Encompass More Asset Management first reported a position in Johnson & Johnson in Q3 2024 and has held it in 8 quarters since.
  • 828 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Encompass More Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.